MTF Quarterly Webcast

Similar documents
DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS. February 201 0

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

MTF Quarterly Webcast June 13, 2013

An Evaluation of the DoD Transdermal Fentanyl Pharmacy Edit. LTC Stacia Spridgen, MSC, USA Director, DoD Pharmacoeconomic Center

I. UNIFORM FORMULARY REVIEW PROCESS

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 24 June 2010

Lantus to levemir conversion

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 25 March 2010

8/13/2016. Insulin Basics. Rapid-Acting Insulin Analogs. Current Insulin Products and Pens. Basal Insulin Analogs. History of Insulin Therapy

DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INTERIM MEETING

Basal Insulin Drug Class Prior Authorization Protocol

Issues for Part D Compliance

Calgary Long Term Care Formulary

MTF Quarterly Webcast March 14, 2013

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

MTF Quarterly Webcast September 9, CDR Joe Lawrence Director, DoD Pharmacoeconomic Center

A thesis presented to the Faculty of the U.S. Army Command and General Staff College in partial fulfillment of the requirements for the degree

Calgary Long Term Care Formulary

MTF Quarterly Webcast September 12, 2013

Determinants of Dispensing Location in the TRICARE Senior PharmacyProgram

Toujeo conversion to lantus

Update to HMO Drug Formulary Tier Definitions. February 8, 2018

Conversion from lantus to tresiba

Insulins: Prices, Rebates, and Other Factors Influencing Costs. May 2018

Coventry Health Care of Georgia, Inc.

Disclosures. Learning Objectives 4/26/2017


Pharmaceutical Management Medicaid 2019

Drugs That Require Step Therapy (ST)

Absolute Pharmacy is the prescription for what ails you. Table of Contents

PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S.

Conversion of lantus to toujeo

Toujeo to lantus conversion

Concentrated Insulin & Patient Management THE QUALITY CENTER PATIENT SAFETY ORGANIZATION FEBRUARY 27, 2018

POLICY AND PROCEDURE DOCUMENT NAME: Drug Recall Notification Process

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

Drugs That Require Step Therapy (ST)

Drugs That Require Step Therapy (ST)

II. UNIFORM FORMULARY CLASS REVIEWS Phosphodiesterase Type-5 (PDE-5) INHIBITORS FOR PULMONARY ARTERIAL HYPERTENSION (PAH) P&T Comments

Drug Effectiveness Review Project Summary Report Long acting Insulins

Short-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins

Converting lantus to humalog 75 25

Capital Health Plan CMS Star Ratings Strategies for Improvement

II. Angiotensin Receptor Blockers (ARBs) Drug Class Review

Substance Use and Misuse in the Military

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

MTF Quarterly Webcast December 9, 2010

Diabetes Update: Keeping patients safe. Victoria Ruszala MFRPSII North Bristol NHS Trust

OHSU Drug Effectiveness Review Project Summary Report Long-Acting Insulins

Getting started with Prime

EXECUTIVE SUMMARY. Uniform Formulary (UF) Beneficiary Advisory Panel (BAP) I. INTERIM MEETING: UF CLASS REVIEWS-PROTON PUMP INHIBITORS (PPis)

Summary ofpanel Vote/Comments:

Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies

Idaho DUR Board Meeting Minutes

Drug Coverage for EpiPens to Change July 1

Buprenorphine used in the treatment of opioid dependence: availability and price

Tools for Targeting High Risk Patients in Your Practice. Statement of Disclosure

Levemir vs lantus dose conversion

PHARMACY COMPLIANCE RISK AREAS FOR 2014

Part D Pharmacy. An Independent Licensee of the Blue Cross Blue Shield Association ( )

Department of Defense Pharmacoeconomic Center 2421 Dickman Rd., Bldg. 1001, Rm. 310 Fort Sam Houston, TX

CHAPTER 7 SECTION 24.1 PHASE I, PHASE II, AND PHASE III CANCER CLINICAL TRIALS TRICARE POLICY MANUAL M, AUGUST 1, 2002 MEDICINE

Department of Defense Pharmacoeconomic Center 2421 Dickman Rd., Bldg. 1001, Rm. 310 Fort Sam Houston, TX

Authorization and appeals kit: Psoriatic arthritis

Rationale for Decision Excluded Generic OTC equivalent available (Flonase Allergy Relief) Medicare status (if differs)

Pharmacy Policy Bulletin

Unit 204 Assist with the assembly of prescribed items

Spending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin Prices

Frequently asked questions

Objectives. Key Elements. ICAHN Targeted Focus Area: Drug Information and Drug Standardization and Distribution 3/24/2014

DECISION PAPER DEPARMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS. November 2013

Ophthalmic-1s: Antihistamine and Dual Acting Antihistamine/Mast Cell Stabilizers DHA Formulary Management Branch

Stephen C. Joseph, M.D., M.P.H.

LEVEMIR (insulin detemir) subcutaneous solution LEVEMIR FLEXTOUCH (insulin detemir) subcutaneous solution pen-injector

Triage Information: 1. Duration of HPSJ Membership 2. Age 3. Fill history of Seasonal Allergy Medications

Drug Utilization Review & Cost Reduction Strategies. Esther Liu, PharmD, MSIA, CGP Clinical Pharmacist Outcome Resources

Pharmacy Audit Recovery Guidelines

MTF Quarterly Webcast December 13, 2012

Objectives. Navigating New Insulins. Disclosures. Diabetes: The Stats. Normal Insulin Release Individuals without diabetes. History of Insulin 5/23/17

A Step-by-Step Guide for Rubicon Pharmacists Delivering the RubiReview Program (SMAP)

Pharmacy Plan Guidance

Uniform Formulary Beneficiary Advisory Panel. Meeting Summary June Washington. D.C.

DIRECTORY Pharmacy

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

An Epic Battle Pharmacist Heroes vs. Shortages

EXAMPLE ONLY. RxBIN Issuer (80840) ID NAME Drew Zehnder. Houston Methodist 6565 Fannin Street, GB164 Houston, TX 77030

Sunderland Diabetes Network - Recommendations for safe prescribing of insulin.

Medicare Part D Overutilization Monitoring System

Oral Agents. Formulary Limits. Available Strengths. IR: 4mg ER: 12mg Syrup: 2mg/5ml

Chapter 18 Section 2. EXPIRED - Department Of Defense (DoD) Cancer Prevention And Treatment Clinical Trials Demonstration

TABLE OF CONTENTS (Click on a link below to view the section.)

Authorization and appeals kit: Moderate to severe plaque psoriasis coexisting with psoriatic arthritis

Understanding Your Patient Care Opportunity Report (PCOR)

Brown-Lupton Health Service Texas Christian University Campus P.O. Box Fort Worth, TX Dear Student,

Welcome - we will begin the webinar shortly Please read the participation tips below:

July 5, Dear Parents:

Comparative Storage and Utilization Analysis of Insulin Across Inpatient Hospital Settings

Department of Defense Pharmacoeconomic Center 1750 Greeley Rd., Bldg. 4011, Rm. 217 Fort Sam Houston, TX

Transcription:

TMA Fort Sam Houston, TX MTF Quarterly Webcast LTC Stacia Spridgen Director, 1

Introduction Greetings from the PEC Purpose of the Quarterly MTF Webcast DCO Ground Rules Type questions into DCO system Put on mute, not on hold - Contingency plan if DCO system quits working 2

Review of P&T Activities Teresa M. Anekwe, PharmD, BCPS Clinical Pharmacist 3

Basal insulins Uniform Formulary (UF) Basal Insulins Non-Formulary Basal Insulins Basal Insulins on BCF MTFs must have on formulary Basal Insulins not on BCF MTFs may have on formulary Basal Insulins MTFs must not have on formulary Insulin glargine 100 u/ml 10 ml vial (Lantus) 3 ml pens (SoloStar) Insulin detemir 100 u/ml 10 ml vial (Levemir) Insulin detemir 100 u/ml 3 ml pen (Flexpen)

Clotting Factors The factor VIII product Xyntha be designated as ECF on the UF. The factor IX product BeneFIX be designated as ECF on the UF.

Formulary Items retain formulary status on the UF Guanfacine ER (Intuniv) Morphine ER/naltrexone (Embeda) retained

NF a. The following drugs were designated nonformulary on the Uniform Formulary (UF): i. Telmasartan/amlodipine (Twynsta) ii. iii. Aliskiren/valsartan (Valturna) Zolpidem sublingual (Edluar) All have 60 day implementation dates

Other items PDE-5 use for post prost up to 1 year Sumavel (sumatriptan needleless) QL VA-DoD insulin contact 703 update Prices take 2 weeks to load

Ongoing and future meetings May expect signing late June/early July Lipids BPH drugs Aug ARB/ACE/DRI and combos Eye NSAID/Mast Cell Stabilizers/Antihistamines

Website: Formulary Search Tool Dr. Jeremy Briggs PharmD, MBA, Lean Six Sigma Black Belt Industry Liaison 10

New TRICARE Formulary Search Tool 11

Start of Search 12

Type in brand or generic name 13

Result(s) show only drug name 14

Dosage is new to the TRICARE Formulary Search Tool 15

Final Result brings all relevant drug information into one page 16

Basic Core Formulary (BCF) Tag 17

Extended Core Formulary (ECF) Tag 18

ECF Webpage 19

Uniform Formulary (Not BCF or ECF) 20

Non-Formulary 21

Notes Age limits Gender limits Quantity limits Clarifications on Kits, each etc. Customizable notes 22

Prior Authorization and Medical Necessity Criteria and Forms associated with a drug now appear in the final search result Decreased time to find correct form Table with all PAs and MNs still available 23

Alternatives Currently using AHFS classification for alternatives Expect to see a change to PEC Classification in the near future Order of appearance is from lowest to highest Tier 24

Pharmaceutical Contracting Issues Dr. Jeremy Briggs PharmD, MBA, Lean Six Sigma Black Belt Industry Liaison 25

Possible Cost Avoidance Compare: Pricing Twinject Epipen Adrenaclick 26

Flonase Shortage due to Apotex (30% of market) no longer making generic product Prasco stopped making 31 May 2010 Large price disparity Alternatives: Flunisolide is now on National Contract Mometasone (Nasonex) 27

Warfarin National Contract item Hazardous waste Unit dose is for inpatient use only 28

MTF Prescription Restriction Program Hector Morales Deputy Director, TMA Pharmacy Operations Center 29

MTF Prescription Restriction Process 1. MTF providers identify beneficiary who may have drug seeking behavior or high risk of harming self or others 2. Use Pharmacy Data Transaction Service (PDTS) to set restriction 3. The provider has the option to: 1. Restrict all meds to a specific pharmacy and/or provider 2. Restrict controlled meds to a specific provider or list of providers 3. Exclude controlled substances or specific non-controlled substance(s) at mail order or retail pharmacy o The restriction form is available on the PEC website: https://rxnet.army.mil/pec/pdts/pdts_mtfs.php?submenuheader=0 30

31

Medication Restriction Program MTF communicates to the POC which restriction type to manage pharmacy benefit Requires signature and coordination of the Triad Team comprised of the Provider, Nurse Case Manager, and the MTF Pharmacist Coordination between Triad Team and POC when SM is on leave or transfers for care Civilian-Based Pharmacy Restriction Program AD Members assigned to CBWTU Community-based Pharmacy Restriction Form Specific retail network pharmacy Specific network provider For Restriction Removal or temporary lift: Contact the POC at 1-866-275-4732 option 8 or send e-mail to: pdts.ameddcs@amedd.army.mil 32

Retail Medication Restriction Program (1-1-1) Express Scripts, Inc. (ESI) identifies members quarterly ESI sends data to Managed Care Support Contractor (MCSC) to examines medical & pharmacy claims to include / exclude in program ESI generates letters to members to select pharmacy, provider & medical facility Letters not returned in 60 days or undeliverable are set at 100% Prepayment on all control meds Member returns letter with selections ESI sends information to POC to enter selections in PDTS 33

Future initiatives Enhanced messaging (PRODUR Warnings) between PDTS and CHCS for MTFs Providers/Pharmacy will receive warning of beneficiary restriction 34

OCONUS Restriction on Mail Order Pharmacy Mr Hector Morales Deputy Director, TMA Pharmacy Operations Center 35

PEC Contact Info 210-295-1271 (DSN 421-1271) For PEC Clinical Staff, 1-866-ASK 4 PEC (275-4732) Pharmacy Operation Center PECWEB@amedd.army.mil Website issues pdts.ameddcs@amedd.army.mil Questions, assistance with PDTS, Business Objects PECUF@amedd.army.mil Clinical, Formulary questions 36

Questions? 37